Merck Completes Acquisition of Terns Pharmaceuticals, Inc.

Merck: 'Strong Buy' - Terns Acquisition And Ability To Counter Keytruda Patent Loss

Buy, Sell or Hold MRK Stock With Q1 Earnings Around the Corner?

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders?

Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN

Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders?

Why Terns Pharmaceuticals Stock Rocked the Market in March

Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review

Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.

Shareholder Alert: Ademi LLP investigates whether Terns Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders

Capricorn Fund Managers Ltd Takes $6.12 Million Position in Terns Pharmaceuticals, Inc. $TERN

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Arista Networks, Block, Colgate-Palmolive, Digital Realty, Emerson Electric, MiniMed, Shake Shack, and More

Here Are Friday’s Top Wall Street Analyst Research Calls: Brown-Forman, Chord Energy, Emerson Electric, FuboTV, Genmab, Honeywell, Knight-Swift, Wix.Com, and More

Merck to Boost Oncology Pipeline With $6.7B Terns Buyout, Stock Up

E. Ohman J or Asset Management AB Sells 81,208 Shares of Terns Pharmaceuticals, Inc. $TERN

Terns Pharmaceuticals (NASDAQ:TERN) Sets New 12-Month High – Here’s Why

Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Terns Pharmaceuticals, Inc. (NASDAQ: TERN)

Nasdaq, Dow Jones finish session ahead, oil price softens as US pushes for Iran peace talks

Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: Analyst

Merck to acquire Terns Pharmaceuticals for $6.7B

Shareholder Alert: The Ademi Firm investigates whether Terns Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders

TERN Stock Alert: Halper Sadeh LLC is Investigating Whether Terns Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline

Merck boosts cancer portfolio with $6.7 billion buyout of Terns Pharma

Merck Reaches Nearly $6 Billion Deal for Cancer Biotech Terns

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

Merck nears $6 billion all-cash deal to buy Terns Pharma, FT reports

As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors?

Terns Pharmaceuticals (NASDAQ:TERN) Reaches New 1-Year High – Should You Buy?

This Biotech Fund Sold $8 Million of Terns Stock Last Quarter, but Here's Why It Still Seems Very Bullish

This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally

Terns Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:TERN)

4 Biotech Stocks to Watch for Potential Upside in 2026

Dynamic Technology Lab Private Ltd Grows Stock Position in Terns Pharmaceuticals, Inc. $TERN

What Smart Money Knows and a Broker Would Never Tell You

DLD Asset Management LP Cuts Stake in Terns Pharmaceuticals, Inc. $TERN

The Market Has Changed… Have You?

Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing

The Market Isn’t Flat. It’s Rotating – And AI Is the Trigger

Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences

ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Average Rating of “Moderate Buy” by Brokerages

Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge

Wall Street Analysts See a 50.91% Upside in Terns Pharmaceuticals (TERN): Can the Stock Really Move This High?